Intracellular Bacteria and Protozoa - Intracellular Delivery: Fundamentals and Applications - page 795

Agrawal AK, Singhal A, Gupta CM (1987) Functional drug targeting to erythrocytes in vivo using
antibody bearing liposomes as drug vehicles. Biochem Biophys Res Commun 148: 357-361
Agrawal AK, Agrawal A, Pal A, Guru PY, Gupta CM (2002) Superior chemotherapeutic efficacy
of amphotericin B in tuftsin-bearing liposomes against Leishmania donovani infection in
hamsters. J Drug Target 10: 41-45
Ahmad Z, Sharma S, Khuller GK (2005) Inhalable alginate nanoparticles as antitubercular drug
carriers against experimental tuberculosis. Int J Antimicrob Agents 26: 298-303
Ahmad Z, Sharma S, Khuller GK (2006 a) Azole antifungals as novel chemotherapeutic agents
against murine tuberculosis. FEMS Microbiol Lett 261: 181-186
Ahmad Z, Pandey R, Sharma S, Khuller GK (2006 b) Pharmacokinetic and pharmacodynamic
behavior of antitubercular drugs encapsulated in alginate nanoparticles at two doses. Int
J Antimicrob Agents 27: 409-416
Ahmad Z, Sharma S, Khuller GK (2007) Chemotherapeutic evaluation of alginate nanoparticle-
encapsulated azole antifungal and antitubercular drugs against murine tuberculosis.
Nanomedicine 3: 239-243
Ahmad Z, Pandey R, Sharma S, Khuller GK (2008) Novel chemotherapy for tuberculosis: chemo-
therapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles. Int
J Antimicrob Agents 31: 142-146
Akinlolu AA, Shokunbi MT (2010) Neurotoxic effects of 25 mg/kg/bodyweight of artemether on
the histology of the trapezoid nuclei and behavioural functions in adult male Wistar rats. Acta
Histochem 112: 193-198.
Alonso MJ (2004) Nanomedicines for overcoming biological barriers. Biomed Pharmacother 58:
168-172
Alving CR, Steck EA, Chapman WL, Waits VB, Hendricks LD, Swartz GM Jr, Hanson WL
(1978) Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs. Proc
Natl Acad Sci USA 75: 2959-2963
Ancsin JB, Kisilevsky R (2004) A binding site for highly sulfated heparan sulfate is identified in
the N terminus of the circumsporozoite protein: significance for malarial sporozoite attach-
ment to hepatocytes. J Biol Chem 279: 21824-21832
Andrew NW (1994) From lysosomes into the cytosol: the intracellular pathway of Trypanosoma
cruzi. Braz J Med Biol Res 27: 471-475
Antosova Z, Mackova M, Kral V, Macek T (2009) Therapeutic application of peptides and pro-
teins: parenteral forever?. Trends Biotechnol 27: 628-634
Arana BA, Mendoza CE, Rizzo NR, Kroeger A (2001) Randomized, controlled, double-blind trial
of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium
chloride ointment in Guatemala. Am J Trop Med Hyg 65: 466-470
Armijos RX, Weigel MM, Calvopina M, Mancheno M, Rodriguez R (2004) Comparison of the
effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New
World cutaneous leishmaniasis. Acta Trop 91: 153-160
Asanuma K, Kenji H, Shimazak S (1983) A study concerning the distribution of OTC and CTC
in lung and blood of pigs. J Anim Drugs 6: 1-6
Asilian A, Jalayer T, Whitworth JA, Ghasemi RL, Nilforooshzadeh M, Olliaro P (1995) A ran-
domized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) oint-
ment for treatment of cutaneous leishmaniasis in Iran. Am J Trop Med Hyg 53: 648-651
Azarmi S, Roa WH, Lobenberg R (2008) Targeted delivery of nanoparticles for the treatment of
lung diseases. Adv Drug Deliver Rev 60: 863-875
Banu S, Gordon SV, Palmer S, Islam MR, Ahmed S, Alam KM, Cole ST, Brosch R (2004)
Genotypic analysis of Mycobacterium tuberculosis in Bangladesh and prevalence of the
Beijing strain. J Clin Microbiol 42(2): 674-82
Barratt B, Legrand P (2005) Comparison of the effi cacy and pharmacology of formulations of
amphotericin B used in treatment of leishmaniasis. Curr Opin Infect Dis 18: 527-530
Bayomi MA, Al-Angary AA, Al-Meshal MA, Al-Dardiri MM (1998) In vivo evaluation of
arteether liposomes. Int J Pharm 175: 1-7